QF
TVTX icon

QVT Financial’s Travere Therapeutics TVTX Stock Holding History

QVT Financial’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-296,570
Closed -$6.01M – 86
2015
Q3 		$6.01M Buy
+296,570
New +$8.78M 0.21% 63
2015
Q2 		– Sell
-308,989
Closed -$7.4M – 93
2015
Q1 		$7.4M Sell
308,989
-958,721
-76% -$14.6M 0.41% 55
2014
Q4 		$15.2M Sell
1,267,710
-1,054,747
-45% -$10.9M 0.76% 36
2014
Q3 		$20.7M Buy
2,322,457
+34,874
+2% +$410K 1.06% 35
2014
Q2 		$26.5M Hold
2,287,583
– – 1.44% 25
2014
Q1 		$47.9M Buy
+2,287,583
New +$35.2M 2.74% 11

Other funds holding TVTX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial's TVTX Position: Q4 2015 in Review

QVT Financial sold out of Travere Therapeutics (TVTX) in Q4 2015, closing a stake of 296,570 shares — an estimated $6.01M sold.

QVT Financial first reported a position in TVTX in Q1 2014 and held it in 6 quarters. The position peaked at $47.9M in Q1 2014. 116 funds tracked by Wall St. Rank hold TVTX as of Q4 2015.

  • QVT Financial reported no remaining Travere Therapeutics position as of Q4 2015 after selling out during the quarter.
  • QVT Financial sold 296,570 Travere Therapeutics shares in Q4 2015, an estimated $6.01M.
  • QVT Financial first reported a position in Travere Therapeutics in Q1 2014 and held it in 6 quarters.
  • QVT Financial's Travere Therapeutics position peaked at $47.9M in Q1 2014.
  • 116 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2015.

Based on QVT Financial's 13F filing for Q4 2015, filed 16 Feb 2016.